Early animal model evaluation of an implantable contrast agent to enhance magnetic resonance imaging of arterial bypass vein grafts

Abstract

Background

Non-invasive monitoring of autologous vein graft (VG) bypass grafts is largely limited to detecting late luminal narrowing. Although magnetic resonance imaging (MRI) delineates vein graft intima, media, and adventitia, which may detect early failure, the scan time required to achieve sufficient resolution is at present impractical.

Purpose

To study VG visualization enhancement in vivo and delineate whether a covalently attached MRI contrast agent would enable quicker longitudinal imaging of the VG wall.

Material and Methods

Sixteen 12-week-old male C57BL/6J mice underwent carotid interposition vein grafting. The inferior vena cava of nine donor mice was treated with a gadolinium-diethylenetriaminepentaacetic acid (Gd-DTPA)-based contrast agent, with control VGs labeled with a vehicle. T1-weighted (T1W) MRI was performed serially at postoperative weeks 1, 4, 12, and 20. A portion of animals was sacrificed for histopathology following each imaging time point.

Results

MRI signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) were significantly higher for treated VGs in the first three time points (1.73 × higher SNR, P = 0.0006, and 5.83 × higher CNR at the first time point, P = 0.0006). However, MRI signal enhancement decreased consistently in the study period, to 1.29 × higher SNR and 2.64 × higher CNR, by the final time point. There were no apparent differences in graft morphometric analyses in Masson’s trichrome-stained sections.

Conclusion

A MRI contrast agent that binds covalently to the VG wall provides significant increase in T1W MRI signal with no observed adverse effects in a mouse model. Further optimization of the contrast agent to enhance its durability is required.

Keywords

Magnetic resonance imaging gadolinium image enhancement contrast media signal-to-noise ratio vascular grafting peripheral vascular diseases

Get full access to this article

View all access options for this article.

References

Alexander

Hafley

Harrington

et al.

Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA 2005; 294: 2446–2454.

Berceli

Hevelone

Lipsitz

et al.

Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial. J Vasc Surg 2007; 46: 1173–1179.

Kirby

Brady

Thompson

et al.

The Vein Graft Surveillance Trial: rationale, design and methods. VGST participants. Eur J Vasc Endovasc Surg 1999; 18: 469–474.

Baldus

Koster

Elsner

et al.

Treatment of aortocoronary vein graft lesions with membrane-covered stents: A multicenter surveillance trial. Circulation 2000; 102: 2024–2027.

Mills

SR Wixon

James

et al.

The natural history of intermediate and critical vein graft stenosis: recommendations for continued surveillance or repair. J Vasc Surg 2001; 33: 273–278. discussion 278–280.

Lau

Ridley

Bannon

et al.

Lumen loss in the first year in saphenous vein grafts is predominantly a result of negative remodeling of the whole vessel rather than a result of changes in wall thickness. Circulation 2006; 114: I435–440.

Kaneda

Terashima

Takahashi

et al.

Mechanisms of lumen narrowing of saphenous vein bypass grafts 12 months after implantation: an intravascular ultrasound study. Am Heart J 2006; 151: 726–729.

Kalra

Miller

et al.

Early remodeling of saphenous vein grafts: proliferation, migration and apoptosis of adventitial and medial cells occur simultaneously with changes in graft diameter and blood flow. J Vasc Res 2000; 37: 576–584.

Jiang

Tao

et al.

TGF-beta- and CTGF-mediated fibroblast recruitment influences early outward vein graft remodeling. Am J Physiol Heart Circ Physiol 2007; 293: H482–488.

10.

Chatterjee

Stoll

Denning

et al.

Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res 2009; 104: 541–549.

11.

Robinson

Taylor

et al.

Beyond the adventitia: exploring the outer limits of the blood vessel wall. Circ Res 2009; 104: 416–418.

12.

Banno

Takei

Muramatsu

et al.

Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts. J Vasc Surg 2006; 44: 633–641.

13.

Murday

Gershlick

Syndercombe-Court

et al.

Intimal hyperplasia in arterial autogenous vein grafts: a new animal model. Cardiovasc Res 1983; 17: 446–451.

14.

Bassiouny

White

Glagov

et al.

Anastomotic intimal hyperplasia: mechanical injury or flow induced. J Vasc Surg 1992; 15: 708–716.

15.

Davies

Hagen

et al.

Pathophysiology of vein graft failure: a review. Eur J Vasc Endovasc Surg 1995; 9: 7–18.

16.

Motwani

Topol

et al.

Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998; 97: 916–931.

17.

Hoch

Stark

Van Rooijen

et al.

Macrophage depletion alters vein graft intimal hyperplasia. Surgery 1999; 126: 428–437.

18.

Mann

Whittemore

Donaldson

et al.

Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial. Lancet 1999; 354: 1493–1498.

19.

Jiang

Miller

et al.

A novel vein graft model: adaptation to differential flow environments. Am J Physiol Heart Circ Physiol 2004; 286: H240–H245.

20.

Conte

Bandyk

Clowes

et al.

Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 2006; 43: 742–751.

21.

Donadoni

Pichardo-Almarza

Bartlett

et al.

Patient-specific, multi-scale modeling of neointimal hyperplasia in vein grafts. Front Physiol 2017; 8: 226–226.

22.

Mitsouras

Owens

Conte

et al.

In vivo differentiation of two vessel wall layers in lower extremity peripheral vein bypass grafts: application of high resolution inner-volume black blood 3D FSE. Magn Reson Med 2009; 62: 607–615.

23.

Mitsouras

Mulkern

Owens

et al.

High-resolution peripheral vein bypass graft wall studies using high sampling efficiency inner volume 3D FSE. Magn Reson Med 2008; 59: 650–654.

24.

Mitsouras

Mulkern

Rybicki

et al.

Strategies for inner volume 3D fast spin echo magnetic resonance imaging using nonselective refocusing radio frequency pulses. Med Phys 2006; 33: 173–186.

25.

Terry

Kim

et al.

Longitudinal assessment of hyperplasia using magnetic resonance imaging without contrast in a porcine arteriovenous graft model. Acad Radiol 2009; 16: 96–107.

26.

Rybicki

Mitsouras

Owens

et al.

Lower extremity peripheral vein bypass graft wall thickness changes demonstrated at 1 and 6 months after surgery with ultra-high spatial resolution black blood inner volume three-dimensional fast spin echo magnetic resonance imaging. Int J Cardiovasc Imaging 2008; 24: 529–533.

27.

Rybicki

Mitsouras

Owens

et al.

Multi-contrast high spatial resolution black blood inner volume three-dimensional fast spin echo MR imaging in peripheral vein bypass grafts. Int J Cardiovasc Imaging 2010; 26: 683–691.

28.

Crowe

Gatehouse

Yang

et al.

Volume-selective 3D turbo spin echo imaging for vascular wall imaging and distensibility measurement. J Magn Reson Imaging 2003; 17: 572–580.

29.

Luk-Pat

Gold

Olcott

et al.

High-resolution three-dimensional in vivo imaging of atherosclerotic plaque. Magn Reson Med 1999; 42: 762–771.

30.

Mitsouras D, Mulkern RV, Maier SE. Multicomponent T2 relaxation studies of the avian egg. Magn Reson Med. 2016;75(5):2156–64.

31.

Gold

Han

Stainsby

et al.

Musculoskeletal MRI at 3.0 T: relaxation times and image contrast. AJR Am J Roentgenol 2004; 183: 343–351.

32.

Mitsouras

Vemula

et al.

Immobilized contrast enhanced (ICE) MRI: Gadolinium-based long-term MR contrast enhancement of the vein graft vessel wall. Magn Reson Med 2011; 65: 176–183.

33.

Nguyen

Vemula

Mitsouras

et al.

Immobilization of iron oxide magnetic nanoparticles for enhancement of vessel wall magnetic resonance imaging - an ex vivo feasibility study. Bioconjug Chem 2010; 21: 1408–1412.

34.

Sarkar

Vemula

Teo

et al.

Chemical engineering of mesenchymal stem cells to induce a cell rolling response. Bioconjug Chem 2008; 19: 2105–2109.

35.

Nguyen

Tao

et al.

Mouse vein graft hemodynamic manipulations to enhance experimental utility. Am J Pathol 2011; 178: 2910–2919.

36.

Nguyen

Tao

et al.

Rationale and practical techniques for mouse models of early vein graft adaptations. J Vasc Surg 2010; 21. 52:444–452.

37.

Katayama

Yamaguchi

Kozuka

et al.

Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990; 175: 621–628.